TWO TONE BAN
DEAD

Serial Number

88425659

Owner

Aphria Inc.

Attorney

Courtney Thompson

Filing Date

May 10, 2019

Add to watchlist:

No watchlists yet
View on USPTO

TWO TONE BAN Trademark

Serial Number: 88425659

TWO TONE BAN is a trademark filed by Aphria Inc. on May 10, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 31 (Natural Agricultural Products), Class 34 (Smokers Articles). The application is currently no longer active.

Owner Contact Info

Aphria Inc. (125 trademarks)

265 Talbot Street West
Leamington, Ontario N8H4H3 , CA

Entity Type: 99

Trademark Details

Filing Date

May 10, 2019

Registration Date

Not Registered

Goods & Services

Oils derived from hemp for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; hemp related products, namely, oils for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; food products containing hemp, resins, and oils, namely, butter; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD

Medicated bath salts; medicated liquid soaps; disinfectant and anti-bacterial liquid soaps; medicated skin care preparations; Hemp related products, namely, medicinal oils and salves; concentrated medicated pastes for the teeth and gums, for the hair and scalp, and for use on skin rashes; tinctures, tablets and capsules for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; medicated oils, salves, and concentrated pastes for the treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders, and anxiety; tinctures, tablets and capsules each containing resins and oils derived from hemp for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of hemp, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated topical skin creams, medicated bar and liquid soaps; medicated bath additives, namely, bath herbs, bath oils, bath salts; medicated body creams, medicated body oils, medicated face and body lotions, medicated face and body milk, medicated face lotion, and medicated skin care preparations each of the foregoing containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; personal sexual lubricants; transdermal patches containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp derivatives for medicinal use; hemp related products, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from hemp for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD

Smokers' articles, namely, grinders for use with hemp, dried hemp for smoking; derivatives of hemp, namely, processed resins and oils in the nature of liquids for use in electronic cigarettes and oral smokeless vaporizers; e-liquids comprised of hemp derivatives for use in electronic cigarettes and oral smokeless vaporizers for recreational use; smokers' articles, namely, smoking pipes, pouches for use with hemp, lighters for smokers, oral vaporizers for smokers; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD

Live hemp plants; hemp seeds for planting and agricultural use; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis

Filing History

ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Dec 18, 2023 MAB3
ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Dec 18, 2023 MAB3
ABANDONMENT - AFTER EX PARTE APPEAL
Dec 13, 2023 ABN3
EXPARTE APPEAL TERMINATED
Dec 13, 2023 EXPT
EX PARTE APPEAL-REFUSAL AFFIRMED
Sep 29, 2023 EXPA
NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Mar 6, 2023 GNSN
EXAMINERS STATEMENT E-MAILED
Mar 6, 2023 GNES
EXAMINERS STATEMENT - COMPLETED
Mar 6, 2023 CNES
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 3, 2023 JURT
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Jul 15, 2022 GNS1
SUBSEQUENT FINAL EMAILED
Jul 15, 2022 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Jul 15, 2022 CFRC
ASSIGNED TO EXAMINER
May 17, 2022 DOCK
ASSIGNED TO EXAMINER
Mar 9, 2022 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 3, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 3, 2022 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 25, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 25, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 25, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 25, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 25, 2021 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 3, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 3, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 3, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 7, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 6, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 7, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jan 7, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jan 7, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 14, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 14, 2020 CRFA
ASSIGNED TO LIE
Dec 6, 2020 ALIE
EX PARTE APPEAL-INSTITUTED
Dec 4, 2020 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Dec 4, 2020 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Dec 4, 2020 EXAF
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 3, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 3, 2020 GNFN
FINAL REFUSAL E-MAILED
Jun 3, 2020 GNFR
FINAL REFUSAL WRITTEN
Jun 3, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 24, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 24, 2020 CRFA
ASSIGNED TO LIE
Apr 24, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 21, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 21, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 21, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 21, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 15, 2019 DOCK
ASSIGNED TO EXAMINER
May 30, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2019 NWOS
NEW APPLICATION ENTERED
May 14, 2019 NWAP